Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/10/2023 | Series B | $259.8MM | $xx.xx | $576.08MM | ||
Price per Share
$xx.xx
Shares Outstanding
28,137,525
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
|
||||||
01/10/2023 | Series A-3 | $15MM | $xx.xx | $576.08MM | ||
Price per Share
$xx.xx
Shares Outstanding
1,252,854
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
|
||||||
03/26/2020 | Series A-5 | $5.32MM | $xx.xx | $160.84MM | OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,407,617
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners
|
||||||
03/26/2020 | Series A-4 | $5.36MM | $xx.xx | $160.84MM | OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,851,927
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners
|
||||||
03/26/2020 | Series A-1 | $80MM | $xx.xx | $160.84MM | OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners | |
Price per Share
$xx.xx
Shares Outstanding
14,296,176
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed, Colt Ventures, MPM Capital, Vida Ventures, Hunt Technology Ventures, Osage University Partners
|
||||||
12/16/2016 | Series A-2 | $2.08MM | $xx.xx | $4.63MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,126,512
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
500.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|